A 5-day amoxicillin challenge was feasible for evaluating delayed penicillin allergy, with more than 80% of participants completing the protocol; immune‑mediated reactions were uncommon but occurred ...
Company is well positioned following positive FDA Type B meeting outcome, fully enrolled Phase 2 trial for its lead clinical program, and recent $5 million public offering, as commercial operation ...
Qure’s AMT-130 faces FDA efficacy doubts after 12-month data. QURE's upside now hinges on political pressure. Read here for ...
Tycoon2FA has become a leading phishing-as-a-service (PhaaS) platforms, enabling campaigns that reach over 500,000 ...
Physical exertion combined with deep concentration can severely slow down human reaction times. A recent trial reveals that ...
An informational industry analysis examining ingredient-level research, marketing positioning trends, regulatory context, and ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 11:10 AM ESTCompany ParticipantsJan Mikkelsen - President, CEO, ...
Dementia is one of the most feared conditions of old age because it slowly takes away memory, thinking ability, and independence. It affects millions of older adults worldwide and places a heavy ...
Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...